BCI, industry moves, and neural privacy—this week’s signals.
From lab breakthroughs to policy battles shaping neurotech’s future.
From Stroke Recovery to Statewide Consent
Steady Signals in Neurotech Progress
Seeing Signals, Sensing Risks
Cell therapies, real-time BCI speech, and mental privacy battles.
Real-time speech restoration, Neuralink's BCI expansion, and the silence of regulators.
It's been a quiet week, so let's take some time to reflect on how we could make this newsletter best serve you.
From expressive brain-computer speech and ALS survival gains to Neuralink’s $650M raise and UNESCO’s ethics vote—this week reshapes neurotechnology’s future.
Cognixion and Blackrock Neurotech expand global access to a wearable brain-computer interface that blends EEG, AR, and neurofeedback into one research-ready device.
Paradromics hits a milestone with human neural recording, AI transforms diagnostics, and new pathways emerge for preventing Alzheimer’s and detecting dementia early.
BCIs, Ethics & Engineered Minds: From Thought-Control to Genetic Targeting
